Tohoku J. Exp. Med., 2005, 206(3)

Decreased Serum Lipoprotein Levels as a Guide for Clinical Severity in Patients with Idiopathic Dilated Cardiomyopathy

NURZEN SEZGIN, ALPAY T. SEZGIN,1 HAKAN GULLU,1 AYSUN KARABULUT, IRFAN BARUTCU,1 ERGUN TOPAL,1 DEFNE YALCINTAS2 and ISMAIL TEMEL

Departments of Biochemistry, 1Cardiology, Inonu University Medical Faculty, Malatya, and 2Department of Statistics, Baskent University, Adana Research and Practice Center, Adana, Turkey

Hyperlipidemia is a cardiovascular risk factor. In patients with idiopathic dilated cardiomyopathy (IDC), prognostic roles of endogenous lipoproteins are not fully clarified. It has been known that there is a direct relationship between the levels of cytokines (tumor necrosis factor-α [TNF-α] and interleukin-6 [IL-6]) and deteriorating functional classes of heart failure and mortality. The present study compared the levels of circulating TNF-α, IL-6, lipoproteins, and apolipoproteins in patients with stable IDC (n = 28) with those of patients with unstable IDC (n = 26) and controls (n = 24). Mean serum total cholesterol (TC) was significantly lower in stable IDC patients than controls (p < 0.05). In unstable IDC patients, mean serum TC was also lower than controls but not statistically significant. The IDC patients had significantly higher concentrations of IL-6 and TNF-α than the controls (p < 0.01). Serum IL-6 and Apo AI levels were significantly different between stable and unstable IDC patients (p = 0.021 and p = 0.012, respectively). Increased levels of IL-6 were associated with decreased levels of TC (r = −0.266, p = 0.019), LDL-C (r = −0.376, p = 0.001) and apolipoprotein AI (apo AI) (r = −0.495, p < 0.001) in all IDC patients. TNF-α was also inversely related to apo AI (r = −0.455, p < 0.001) and LDL-C (r = −0.364, p = 0.001) in all patients. Thus, elevated serum levels of cytokines in patients with IDC are associated with decreased lipoprotein concentrations, which may indicate impaired prognosis.

keywords —— heart failure; lipoprotein; apolipoprotein; cytokine

===============================

Tohoku J. Exp. Med., 2005, 206, 219-224

Correspondence: Nurzen Sezgin, M.D., Baskent University Adana Research and Practice Center, Department of Biochemistry, Dadaloglu Mah. 39. Sok. No: 6, Yuregir, Adana, 01250 Turkey.

e-mail: nurzensezgin@hotmail.com